In vitro screening for antibacterial activity against public health disease pathogens.
Ended Awarded Last action
- Contract number
- 75N93024F00002
- Awardee
-
Element Materials Technology Iowa City Inc. UEI GAJDDSFFPD89
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $45,248
Award facts
- Contract value 40% obligated
-
- $45,248.00 Current, with exercised options
- $112,448.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Liberty, IA 52317, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$24,752 | |
| Original award | $70,000 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $112.4K delivery order contract to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, on August 14, 2024, with completion expected by August 13, 2025. This firm fixed-price contract supports in vitro screening for antibacterial activity against public health disease pathogens and determination of the in vitro inhibitory effect of experimental antibacterial substances against bacterial pathogens. The contract was issued without a small business set-aside designation and is issued under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle administered by NIAID. Work will be performed in North Liberty, Iowa.
JMI Laboratories is a microbiology specialist that has been registered to receive federal contracts since November 2016 and maintains extensive experience conducting antimicrobial resistance testing and research services for the Department of Health and Human Services. The company specializes in in vitro assessments of antimicrobial activity, minimum inhibitory concentration assays, and analysis of antimicrobial resistance pharmacogenetic relationships to support critical public health challenges related to emerging resistance trends. The firm has previously received multiple awards under the IVAAA contract vehicle and maintains a track record of delivering specialized antimicrobial research support to federal agencies including the Food and Drug Administration and National Institutes of Health.
Quick answers
Who was awarded contract 75N93024F00002?
75N93024F00002 was awarded to Element Materials Technology Iowa City Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 14, 2024.
How much is contract 75N93024F00002 worth?
The government has obligated $45,248 on 75N93024F00002. Its potential value, with all options, is $112,448.
Is contract 75N93024F00002 an order under another contract?
Yes. 75N93024F00002 is a delivery order under 75N93019D00011, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93024F00002 competed?
The extent of competition for 75N93024F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award